384 related articles for article (PubMed ID: 33221711)
1. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [
Patel CB; Beinat C; Xie Y; Chang E; Gambhir SS
Neoplasia; 2021 Jan; 23(1):58-67. PubMed ID: 33221711
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [
Beinat C; Patel CB; Xie Y; Gambhir SS
Mol Imaging Biol; 2020 Feb; 22(1):124-133. PubMed ID: 30989436
[TBL] [Abstract][Full Text] [Related]
3. The Utility of [
Beinat C; Haywood T; Chen YS; Patel CB; Alam IS; Murty S; Gambhir SS
Mol Imaging Biol; 2018 Dec; 20(6):1015-1024. PubMed ID: 29736561
[TBL] [Abstract][Full Text] [Related]
4. A Clinical PET Imaging Tracer ([
Beinat C; Patel CB; Haywood T; Murty S; Naya L; Castillo JB; Reyes ST; Phillips M; Buccino P; Shen B; Park JH; Koran MEI; Alam IS; James ML; Holley D; Halbert K; Gandhi H; He JQ; Granucci M; Johnson E; Liu DD; Uchida N; Sinha R; Chu P; Born DE; Warnock GI; Weissman I; Hayden-Gephart M; Khalighi M; Massoud TF; Iagaru A; Davidzon G; Thomas R; Nagpal S; Recht LD; Gambhir SS
Clin Cancer Res; 2021 Dec; 27(23):6467-6478. PubMed ID: 34475101
[TBL] [Abstract][Full Text] [Related]
5. Development of [
Beinat C; Alam IS; James ML; Srinivasan A; Gambhir SS
Mol Imaging Biol; 2017 Oct; 19(5):665-672. PubMed ID: 28236227
[TBL] [Abstract][Full Text] [Related]
6. PKM2 Modulation in Head and Neck Squamous Cell Carcinoma.
Boschert V; Teusch J; Müller-Richter UDA; Brands RC; Hartmann S
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054968
[TBL] [Abstract][Full Text] [Related]
7. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
[TBL] [Abstract][Full Text] [Related]
9. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
[TBL] [Abstract][Full Text] [Related]
10. The influence of photodynamic therapy on the Warburg effect in esophageal cancer cells.
Gan J; Li S; Meng Y; Liao Y; Jiang M; Qi L; Li Y; Bai Y
Lasers Med Sci; 2020 Oct; 35(8):1741-1750. PubMed ID: 32034563
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
Hu Y; Mu H; Deng Z
Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis.
Han B; Meng X; Chen H; Chen L; Liu X; Wang H; Liu D; Gao F; Lin L; Ming J; Sun B; Yin S; Wang R; Wu P; Cai J; Jiang C
Aging (Albany NY); 2017 Aug; 9(8):1885-1897. PubMed ID: 28858851
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
15. NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells.
Han D; Wei W; Chen X; Zhang Y; Wang Y; Zhang J; Wang X; Yu T; Hu Q; Liu N; You Y
Oncotarget; 2015 Sep; 6(28):26119-28. PubMed ID: 26172294
[TBL] [Abstract][Full Text] [Related]
16. Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells.
Park I; Mukherjee J; Ito M; Chaumeil MM; Jalbert LE; Gaensler K; Ronen SM; Nelson SJ; Pieper RO
Cancer Res; 2014 Dec; 74(23):7115-24. PubMed ID: 25320009
[TBL] [Abstract][Full Text] [Related]
17. PKM2, cancer metabolism, and the road ahead.
Dayton TL; Jacks T; Vander Heiden MG
EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
[TBL] [Abstract][Full Text] [Related]
18. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
Li C; Zhao Z; Zhou Z; Liu R
Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118
[TBL] [Abstract][Full Text] [Related]
19. KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer.
Zhang C; Huang Z
Mol Biotechnol; 2024 Jun; 66(6):1446-1457. PubMed ID: 37294531
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis.
Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L
Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]